Jan 19–22, 2027 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers:
Tomasz Nowakowski, Xin Jin, Stephan Sanders, and Zhaolan (Joe) Zhou
-
Scientific Organizers: Tomasz Nowakowski, Xin Jin, Stephan Sanders, and Zhaolan (Joe) Zhou
Tomasz Nowakowski, PhD
University of California, San Francisco
Xin Jin, PhD
Scripps Research Institute
Stephan Sanders, PhD
University of Oxford
Zhaolan (Joe) Zhou, PhD
University of Pennsylvania
***Meeting program subject to change.
Available Formats: = In Person = On DemandBooking Function
Merchandise Options
Registration Options
Tuesday, January 19, 2027
Wednesday, January 20, 2027
A Journey in Rett Syndrome: From Basic Science Discovery of Causal Gene to Therapies of Patients
Experimental Validation of Common Variants of Neurodevelopmental Disorders
Massively Parallel Dissection of Gene to Phenotype Relationships using Perturb-seq
PARIS: Paris Autism Research International Sib-Pair Study
Genetic and Epigenetic Mechanisms of Cortical Development
Deep Mutational Scanning Approaches to Correlate Structure and Function of Proteins
Kinase Signaling in Neurodevelopmental Disorders
Thursday, January 21, 2027
Transient Connectivity and Circuit Reprogramming in Cortical Development
Spontaneous Activity–Gene Program Interplay in Circuits Development: Implications for Neurodevelopmental Disorders
Asynchrony of Functional Connectivity in Developing Brain of ASD Models
Establishing Tools for Human Neuroscience
Interrogating Human Specific and Neurodevelopmental Risk Genes using Chimeric Models
Brain Organoids to Study Neurodevelopmental Disorders
Friday, January 22, 2027
Epigenetic Dissection of Mechanisms underlying Neurodevelopmental Disorders
Insights into Gene-Environment Interactions in Neurodevelopmental Disorders
Cytokine Regulation of Brain and Behavior
Neonatal Hypoxia and Pediatric Risk Factors
Gene Targeting Strategies for Autism and Neurodevelopmental Disorders
The Parents’ Journey through Drug Development: Making the IMPOSSIBLE POSSIBLE-The Angelman Syndrome Story
Using Human Pluripotent Stem Cell-Derived Neural Cultures to Assess Safety of New Drugs and Chemicals
Saturday, January 23, 2027
Subscribe for Updates